Record NNP B-NP O
date NN I-NP O
: : O O
2124-11-23 CD O B-DATE
SMHFC NNP B-NP B-HOSPITAL
8 CD I-NP O
Intern NN I-NP O
Admission NNP B-NP O
Note NN I-NP O
PATIENT NNP B-NP O
: : O O
Walter NNP B-NP B-PATIENT
Uribe NNP I-NP I-PATIENT
MRN NNP B-NP O
: : O O
4067033 CD O B-MEDICALRECORD
ADMIT NNP B-NP O
DATE NNP I-NP O
: : O O
11/22/24 CD O B-DATE
PCP NNP B-NP O
: : O O
Irvin NNP B-NP B-DOCTOR
Joshua NNP I-NP I-DOCTOR
Morgan NNP I-NP I-DOCTOR
, , O O
MD NNP B-NP O
ATTENDING VBG B-NP O
PHYSICIAN NNP I-NP O
: : O O
William NNP B-NP B-DOCTOR
Dugan NNP I-NP I-DOCTOR
, , O O
MD . O O
CHIEF NNP B-NP O
COMPLAINT NNP I-NP O
Shortness NNP B-NP O
of IN B-PP O
breath NN B-NP O
HISTORY NN B-NP O
OF IN B-PP O
THE DT B-NP O
PRESENT JJ I-NP O
ILLNESS NNS I-NP O
Mr. NNP B-NP O
Uribe NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
56 CD I-NP B-AGE
yo JJ I-NP O
man NN I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
CHF NNP B-NP O
( -LRB- I-NP O
EF NNP I-NP O
61 CD I-NP O
% NN I-NP O
) -RRB- I-NP O
, , I-NP O
COPD NNP I-NP O
, , I-NP O
OSA NNP I-NP O
, , I-NP O
PulmHTN NNP I-NP O
, , I-NP O
HTN NNP I-NP O
, , I-NP O
DMII NNP I-NP O
, , I-NP O
chronic JJ I-NP O
venous JJ I-NP O
stasis NN I-NP O
, , O O
and CC O O
morbid NN B-NP O
obesity NN I-NP O
presenting VBG B-VP O
to TO B-PP O
the DT B-NP O
ED VBN B-VP O
with IN B-PP O
shortness NN B-NP O
of IN B-PP O
breath NN B-NP O
. . O O
Patient NNP B-NP O
has VBZ B-VP O
had VBN I-VP O
2 CD B-NP O
prior JJ I-NP O
admission NN I-NP O
( -LRB- I-NP O
2121 CD I-NP B-DATE
, , I-NP O
2122 CD I-NP B-DATE
) -RRB- I-NP O
for IN B-PP O
CHF NNP B-NP O
exacerbations NNS I-NP O
, , O O
last JJ B-NP O
admission NN I-NP O
requiring VBG I-NP O
lasix NN I-NP O
80 CD I-NP O
IV NNP I-NP O
TID NNP I-NP O
to TO B-VP O
diurese VB I-VP O
1-3L/day JJ B-ADJP O
. . O O
Patient NNP B-NP O
states VBZ B-VP O
his PRP$ B-NP O
dry JJ I-NP O
weight NN I-NP O
is VBZ B-VP O
~380lbs JJ B-ADJP O
. . O O
He PRP B-NP O
was VBD B-VP O
recently RB B-ADVP O
in IN B-PP O
Amboy NNP B-NP B-CITY
after IN B-PP O
surgery NN B-NP O
for IN B-PP O
nonhealing JJ B-NP O
venous JJ I-NP O
stasis NN I-NP O
ulcer NN I-NP O
and CC O O
returned VBD B-VP O
home NN B-NP O
in IN B-PP O
9/24 CD B-NP B-DATE
. . O O
Upon IN B-PP O
returning VBG B-VP O
home NN B-NP O
his PRP$ B-NP O
weight NN I-NP O
was VBD B-VP O
down RB B-ADVP O
to TO B-PP O
342 CD B-NP O
lbs NNS I-NP O
, , O O
however RB B-ADVP O
upon IN B-PP O
admission NN B-NP O
it PRP B-NP O
is VBZ B-VP O
409 CD B-NP O
lbs NNS I-NP O
. . O O
Patients NNS B-NP O
reports VBZ B-VP O
the DT B-NP O
past JJ I-NP O
3 CD I-NP O
weeks NNS I-NP O
he PRP B-NP O
has VBZ B-VP O
felt VBN I-VP O
abdominal JJ B-NP O
bloating NN I-NP O
, , O O
increased VBD B-VP O
LE JJ B-NP O
edema NN I-NP O
and CC I-NP O
increase NN I-NP O
dyspnea NN I-NP O
on IN B-PP O
exertion NN B-NP O
. . O O
At IN B-PP O
baseline NN B-NP O
he PRP B-NP O
is VBZ B-VP O
able JJ B-ADJP O
to TO B-VP O
ambulate VB I-VP O
short JJ B-NP O
distances NNS I-NP O
on IN B-PP O
his PRP$ B-NP O
cane NN I-NP O
however RB B-ADVP O
now RB I-ADVP O
he PRP B-NP O
is VBZ B-VP O
barely RB B-ADJP O
able JJ I-ADJP O
to TO B-VP O
get VB I-VP O
up RP B-PRT O
off IN B-ADVP O
the DT B-NP O
toilet NN I-NP O
. . O O
He PRP B-NP O
also RB B-ADVP O
reports VBZ B-VP O
increased VBN B-NP O
drainage NN I-NP O
from IN B-PP O
his PRP$ B-NP O
RLE NN I-NP O
wound NN I-NP O
. . O O
He PRP B-NP O
reports VBZ B-VP O
medication NN B-NP O
compliance NN I-NP O
except IN B-PP O
for IN B-PP O
missing VBG B-VP O
2-3 JJ B-NP O
times NNS I-NP O
over IN B-PP O
the DT B-NP O
past JJ I-NP O
several JJ I-NP O
weeks NNS I-NP O
. . O O
He PRP B-NP O
reports VBZ B-VP O
increased VBN I-VP O
fluid NN B-NP O
intake NN I-NP O
including VBG B-VP O
Progresso NNP B-NP O
soup NN I-NP O
, , O O
ice NN B-NP O
water NN I-NP O
, , O O
diet NN B-NP O
coke NN I-NP O
and CC O O
a DT B-NP O
&#8216;dash&#8217 CD I-NP O
; : O O
of IN B-PP O
salt NN B-NP O
to TO B-PP O
his PRP$ B-NP O
food NN I-NP O
. . O O
At IN B-PP O
baseline NN B-NP O
he PRP B-NP O
requires VBZ B-VP O
2L JJ B-NP O
O2 NNS I-NP O
during IN B-PP O
the DT B-NP O
day NN I-NP O
and CC O O
4L JJ B-ADJP O
at IN B-PP O
night NN B-NP O
. . O O
His PRP$ B-VP O
CPAP NNP B-NP O
machine NN I-NP O
has VBZ B-VP O
been VBN I-VP O
broken VBN I-VP O
for IN B-PP O
the DT B-NP O
past JJ I-NP O
week NN I-NP O
. . O O
He PRP B-NP O
typically RB B-ADVP O
sleeps VBZ B-VP O
on IN B-NP O
3 CD I-NP O
pillows NNS I-NP O
but CC O O
has VBZ B-VP O
recently RB I-VP O
increased VBN I-VP O
to TO B-PP O
4 CD B-NP O
. . O O
He PRP B-NP O
awakes VBZ B-VP O
from IN B-PP O
sleep NN B-NP O
often RB B-VP O
feeling VBG I-VP O
short JJ B-ADJP O
of IN B-PP O
breath NN B-NP O
and CC O O
sits VBZ B-VP O
on IN B-PP O
the DT B-NP O
edge NN I-NP O
of IN B-PP O
his PRP$ B-NP O
bed NN I-NP O
to TO B-VP O
catch VB I-VP O
his PRP$ B-NP O
breath NN I-NP O
. . O O
Today NN B-VP O
he PRP B-NP O
saw VBD B-VP O
his PRP$ B-NP O
PCP NN I-NP O
at IN B-PP O
Saint NNP B-NP B-HOSPITAL
Mary NNP I-NP I-HOSPITAL
's POS B-NP I-HOSPITAL
Hospital NNP I-NP I-HOSPITAL
Fallbright NNP I-NP I-HOSPITAL
Center NNP I-NP I-HOSPITAL
for IN B-PP O
the DT B-NP O
above JJ I-NP O
complaints NNS I-NP O
and CC O O
was VBD B-VP O
sent VBN I-VP O
immediately RB B-ADVP O
to TO B-PP O
the DT B-NP O
urgent JJ I-NP O
care NN I-NP O
clinic NN I-NP O
. . O O
From IN O O
there RB B-ADVP O
he PRP B-NP O
was VBD B-VP O
transferred VBN I-VP O
to TO B-PP O
the DT B-NP O
HBH NNP I-NP B-HOSPITAL
ED. NNP I-NP O
In IN B-PP O
the DT B-NP O
ambulance NN I-NP O
he PRP B-NP O
received VBD B-VP O
40 CD B-NP O
mg JJ I-NP O
IV NNP I-NP O
lasix NN I-NP O
x NN I-NP O
1 CD B-NP O
and CC O O
had VBD B-VP O
1L DT B-NP O
of IN B-PP O
UOP. NNP B-NP O
In IN B-PP O
the DT B-NP O
ED NNP I-NP O
, , O O
VS NNP B-NP O
were VBD B-VP O
HR NNP B-NP O
106 CD I-NP O
, , O O
BP NNP B-NP O
110/8 CD I-NP O
0 CD I-NP O
RR NNP I-NP O
20 CD I-NP O
O2 NNPS I-NP O
sat VBD B-VP O
96 CD B-NP O
% NN I-NP O
on IN B-PP O
5L. DT B-NP O
He PRP B-NP O
received VBD B-VP O
another DT B-NP O
40mg JJ I-NP O
IV NNP I-NP O
of IN B-PP O
lasix NN B-NP O
and CC O O
put VB B-VP O
out RP B-NP O
800 CD I-NP O
cc NN I-NP O
. . B-NP O
Labs NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
K NNP I-NP O
of IN B-PP O
3.1 CD B-NP O
, , O O
Mg NNP B-NP O
of IN B-PP O
1.4 CD B-NP O
, , O O
Hct NNP B-NP O
of IN B-PP O
35.4 CD B-NP O
and CC O O
BNP NNP B-NP O
of IN B-PP O
1625 CD B-NP O
. . O O
K NNP B-NP O
and CC I-NP O
Mg NNP I-NP O
were VBD B-VP O
repleted VBN I-VP O
. . B-NP O
Diltiazem NNP I-NP O
30mg CD I-NP O
po NN I-NP O
x NN I-NP O
1 CD B-NP O
was VBD B-VP O
given VBN I-VP O
for IN B-PP O
rapid JJ B-NP O
afib NN I-NP O
. . O O
CXR '' O O
showed VBD B-VP O
stable JJ B-NP O
interstitial JJ I-NP O
edema NN I-NP O
. . O O
Patient NNP B-NP O
was VBD B-VP O
admitted VBN I-VP O
to TO B-PP O
medicine NN B-NP O
for IN B-PP O
further JJ B-NP O
work NN I-NP O
up RB B-ADVP O
. . O O
REVIEW NN B-NP O
OF IN B-PP O
SYSTEMS NNP B-NP O
General NNP B-NP O
&#8211 CD I-NP O
; : O O
+weight NN B-NP O
gain NN I-NP O
; : O O
no DT B-NP O
fevers NNS I-NP O
, , O O
chills NNS B-NP O
, , O O
or CC O O
night NN B-NP O
sweats NNS I-NP O
Pulmonary JJ B-NP O
&#8211 NN I-NP O
; : O O
no DT B-NP O
cough NN I-NP O
, , O O
+ IN B-PP O
dyspnea NN B-NP O
, , O O
no DT B-NP O
wheezing NN I-NP O
, , O O
no DT B-NP O
hemoptysis NN I-NP O
Cardiac NNP B-NP O
&#8211 CD I-NP O
; : O O
no DT B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
no DT B-NP O
palpitations NNS I-NP O
, , O O
+ NNP B-NP O
orthopnea NNP I-NP O
, , O O
+ NNP B-NP O
PND NNP I-NP O
Gastrointestinal NNP B-NP O
&#8211 CD I-NP O
; : O O
no DT B-NP O
nausea NN I-NP O
, , O O
vomiting VBG B-VP O
, , O O
diarrhea NN B-NP O
; : O O
no DT B-NP O
constipation NN I-NP O
; : O O
no DT B-NP O
changes NNS I-NP O
in IN B-PP O
appetite NN B-NP O
; : O O
no DT B-NP O
abdominal JJ I-NP O
pain NN I-NP O
Genitourinary JJ B-NP O
&#8211 NN I-NP O
; : O O
no DT B-NP O
dysuria NN I-NP O
, , O O
no DT B-NP O
frequency NN I-NP O
Musculoskeletal NNP B-NP O
&#8211 CD I-NP O
; : O O
left VBN B-NP O
shoulder NN I-NP O
pain NN I-NP O
with IN B-PP O
movement NN B-NP O
Extremity NN B-NP O
&#8211 CD I-NP O
; : O O
+ RB B-NP O
lower JJR I-NP O
extremity NN I-NP O
edema NN I-NP O
Skin NNP B-NP O
&#8211 CD I-NP O
; : O O
weepy JJ B-NP O
RLE NNP I-NP O
lesion NN I-NP O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NN I-NP O
CHF NN B-NP O
TTE NNP B-NP O
6/24 CD I-NP B-DATE
: : O O
EF NNP B-NP O
61 CD I-NP O
% NN I-NP O
with IN B-PP O
dilated JJ B-NP O
LA NNP I-NP O
, , O O
thickened DT B-NP O
aortic JJ I-NP O
leaflets NNS I-NP O
, , O O
dilated VBN B-VP O
RA NNP B-NP O
, , O O
mild JJ B-NP O
pulmonary JJ I-NP O
insufficiency NN I-NP O
with IN B-PP O
RVSP NNP B-NP O
91 CD I-NP O
mmHg NN I-NP O
, , O O
dilated VBN B-NP O
RV NN I-NP O
and CC O O
RVH NNP B-NP O
with IN B-PP O
diffuse NN B-NP O
hypokinesis NN I-NP O
BNP NNP B-NP O
584 CD I-NP O
baseline NN I-NP O
HTN . O O
COPD NNP B-NP O
&#8211 CD I-NP O
; : O O
on IN B-PP O
3L JJ B-NP O
home NN I-NP O
O2 . O O
PFTs NNS B-NP O
2117 CD B-NP B-DATE
&#8211 CD I-NP O
; : O O
FEV1 NNP B-NP O
40 CD B-NP O
% NN I-NP O
predicted VBD B-VP O
, , O O
FVC NNP B-NP O
43 CD I-NP O
% NN I-NP O
pred VBN B-VP O
, , O O
ratio NN B-NP O
95 CD I-NP O
% NN I-NP O
pred VBN B-VP O
, , O O
DLCO NNP B-NP O
72 CD I-NP O
% NN I-NP O
pred VBN B-VP O
, , O O
severe JJ B-NP O
ventilatory NN I-NP O
defect NN I-NP O
with IN B-PP O
mild JJ B-NP O
obstructive JJ I-NP O
defect NN I-NP O
Pulmonary NNP B-NP O
HTN NNP I-NP O
Diabetes NNP B-NP O
mellitus JJ I-NP O
type NN I-NP O
II NNP B-NP O
&#8211 CD I-NP O
; : O O
7/24 CD B-NP B-DATE
HgbA1c NNP I-NP O
6.2 CD I-NP O
Obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
Hypercholesterolemia NNP B-NP O
Lipid JJ B-NP O
panel NN I-NP O
in IN B-PP O
1/22 CD B-NP B-DATE
w/ NN I-NP O
cholesterol NN I-NP O
138 CD B-NP O
, , O O
TG NNP B-NP O
82 CD I-NP O
, , O O
HDL NNP B-NP O
58 CD I-NP O
, , O O
LDL NNP B-NP O
64 CD I-NP O
Chronic NNP B-NP O
venous JJ I-NP O
stasis NN I-NP O
with IN B-PP O
recurrent JJ B-NP O
leg NN I-NP O
ulcers NNS I-NP O
Morbid NNP B-NP O
obesity NN I-NP O
Peripheral NNP B-NP O
neuropathy NN I-NP O
PAST NNP B-NP O
SURGICAL NNP I-NP O
HISTORY NN I-NP O
7/24 CD B-NP B-DATE
&#8211 CD I-NP O
; : O O
skin NN B-NP O
graft NN I-NP O
to TO B-PP O
nonhealing JJ B-NP O
venous JJ I-NP O
stasis NN I-NP O
ulcer NN I-NP O
after IN B-PP O
excisional JJ B-NP O
debridement NN I-NP O
FAMILY NNP B-NP O
HISTORY NN I-NP O
Maternal NNP B-NP O
&#8211 CD I-NP O
; : O O
DM CC O O
Paternal NNP B-NP O
&#8211 CD I-NP O
; : O O
angina CC O O
SOCIAL JJ B-NP O
HISTORY NN I-NP O
Lives NNS B-NP O
in IN B-PP O
Galion NNP B-NP B-CITY
with IN B-PP O
his PRP$ B-NP O
wife NN I-NP O
, , O O
son NN B-NP O
and CC O O
daughter NN B-NP O
who WP B-NP O
lives VBZ B-VP O
downstairs NN B-NP O
. . O O
not RB O B-PROFESSION
working VBG B-VP I-PROFESSION
. . I-VP O
Previously RB I-VP O
worked VBD I-VP O
at IN B-PP O
COMCAST NNP B-NP B-ORGANIZATION
in IN B-PP O
manufacturing NN B-NP B-PROFESSION
and CC B-PP O
at IN B-PP O
VMware NNP B-NP B-ORGANIZATION
. . I-NP O
Tobacco NNP I-NP O
&#8211 CD I-NP O
; : O O
quit VB B-NP O
10 CD B-NP O
yrs NNS I-NP O
ago RB B-ADVP O
, , O O
50 CD B-NP O
pack-year NN I-NP O
history NN I-NP O
. . O O
Rare NNP B-NP O
EtOH. NNP I-NP O
No DT B-NP O
illicits NNS I-NP O
. . O O
ALLERGIES/ADVERS NNP B-NP O
E NNP I-NP O
REACTIONS NNS I-NP O
Keflex NNP B-NP O
MEDICATIONS NNS B-NP O
ON IN B-PP O
ADMISSION NN B-NP O
Fluticasone NN B-NP O
Propionate/salmeterol NNP I-NP O
250/50 CD I-NP O
1 CD I-NP O
PUFF NNP I-NP O
INH NNP I-NP O
BID NNP I-NP O
Tiotropium NNP B-NP O
18 CD I-NP O
MCG NNP I-NP O
INH NNP I-NP O
daily RB O O
Verapamil NNP B-NP O
Hcl NNP I-NP O
SR NNP I-NP O
180 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
daily RB O O
Lisinopril NNP B-NP O
10 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
Furosemide NNP B-NP O
120 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
Metformin NNP B-NP O
500 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
BEFORE NNP I-NP O
BREAKFAST NN I-NP O
AND CC O O
BEFORE VB B-VP O
SUPPER NN B-NP O
Nystatin NNP B-NP O
Powder NNP I-NP O
1 CD I-NP O
APPLICATION NNP I-NP O
TOP NNP I-NP O
BID NNP I-NP O
Acetylsalicylic NN B-NP O
Acid NNP I-NP O
( -LRB- I-NP O
Aspirin NNP I-NP O
) -RRB- I-NP O
325 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
Pravastatin NNP B-NP O
10mg CD I-NP O
daily JJ O O
PHYSICAL NNP B-NP O
EXAMINATION NN I-NP O
VITALS NNS B-NP O
: : O O
T NNP B-NP O
97.9 CD I-NP O
HR NNP I-NP O
90 CD I-NP O
BP NNP I-NP O
127/8 CD I-NP O
6 CD O O
O2 IN B-NP O
sat VBD B-VP O
89 CD B-NP O
% NN I-NP O
on IN B-PP O
5L JJ B-NP O
NC NNP I-NP O
General NNP B-NP O
&#8211 CD I-NP O
; : O O
morbidly RB B-NP O
obese JJ I-NP O
male NN I-NP O
in IN B-PP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
Neck NNP B-NP O
&#8211 CD I-NP O
; : O O
unable JJ B-ADJP O
to TO B-VP O
assess VB I-VP O
JVP NNP B-NP O
due JJ I-NP O
to TO B-PP O
habitus NN B-NP O
Pulmonary JJ B-NP O
&#8211 CD I-NP O
; : O O
moderate JJ B-NP O
crackles NNS I-NP O
in IN B-PP O
bases NNS B-NP O
bilaterally RB B-ADVP O
; : O O
no DT B-NP O
wheezing VBG I-NP O
Cardiac NNP B-NP O
&#8211 CD I-NP O
; : O O
irregular JJ B-NP O
rate NN I-NP O
and CC I-NP O
rhythm NN I-NP O
; : O O
S1 NNP B-NP O
and CC I-NP O
S2 NNP I-NP O
normal JJ I-NP O
; : O O
no DT B-NP O
murmurs NNS I-NP O
; : O O
unable JJ B-ADJP O
to TO B-VP O
palpate VB I-VP O
pedal NN B-NP O
pulses NNS I-NP O
Abdomen NNP B-NP O
&#8211 CD I-NP O
; : O O
obese NN B-NP O
, , I-NP O
soft JJ I-NP O
, , I-NP O
distended JJ I-NP O
; : O O
non-tender JJ B-NP O
; : O O
normal JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
Extremity NN B-NP O
&#8211 CD I-NP O
; : O O
edematous JJ B-NP O
, , I-NP O
3+ JJ I-NP O
pitting NN I-NP O
, , O O
erythematous JJ B-ADJP O
with IN B-PP O
ace NN B-NP O
bandages NNS I-NP O
on IN B-PP O
LE JJ B-NP O
bilaterally NN I-NP O
, , O O
warm JJ O O
Skin NNP B-NP O
&#8211 NNS I-NP O
; : O O
chronic JJ B-NP O
venous JJ I-NP O
stasis NN I-NP O
changes NNS I-NP O
on IN B-PP O
LE JJ B-NP O
LABORATORIES NNS B-NP O
11/22/24 CD O B-DATE
137 CD O O
93L . O O
18 CD O O
92 CD O O
3.1L CD O O
36.5H CD O O
0.88 CD O O
eGFR&gt NN B-NP O
;60 CD I-NP O
Ca8.6 . O O
P2.9 . O O
Mg1.4 . O O
Alb3.6 . O O
Glob4.5H . O O
TP8.1 . O O
ALT10 . O O
AST24 . O O
AlkP101 . O O
DBil0.3 CD O O
TBil0.9 . O O
MBneg . O O
BNP1625H . O O
11/22/24 CD O O
5.3 CD O O
11.1L CD O O
237 CD O O
35.4L CD O O
P63 . O O
L22 . O O
E5 . O O
Bs0 . O O
USG1.010 . O O
UAlbneg NN B-NP O
UBldneg NN B-NP O
ULeukneg NN B-NP B-DATE
UNitneg IN O O
UpH6.0 . O O
UKetneg NN B-NP O
MICROBIOLOGY JJ O O
- : O O
None NN B-NP O
RADIOLOGICAL NNP B-NP O
STUDIES NNS I-NP O
CXR NNP B-NP O
&#8211 CD I-NP O
; : O O
low JJ B-NP O
lung NN I-NP O
volumes NNS I-NP O
with IN B-PP O
stable JJ B-NP O
interstitial JJ I-NP O
edema NN I-NP O
EKG NNP B-NP O
&#8211 CD I-NP O
; : O O
Sinus NNP B-NP O
rhythm NN I-NP O
with IN B-PP O
PACs NNS B-NP O
, , O O
LAE NNP B-NP O
, , O O
incomplete JJ B-ADJP O
RBBB NNP B-NP O
&#8211 CD I-NP O
; : O O
unchanged JJ B-ADJP O
from IN B-PRT O
prior RB O O
ASSESSMENT NNP B-NP O
AND CC I-NP O
PLAN NNP I-NP O
Mr. NNP B-NP O
Uribe NNP I-NP O
is VBZ B-VP O
a DT B-NP O
56 CD I-NP O
yo JJ I-NP O
man NN I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
CHF NNP B-NP O
( -LRB- I-NP O
EF NNP I-NP O
61 CD I-NP O
% NN I-NP O
) -RRB- I-NP O
, , I-NP O
COPD NNP I-NP O
, , I-NP O
OSA NNP I-NP O
, , I-NP O
PulmHTN NNP I-NP O
, , I-NP O
HTN NNP I-NP O
, , I-NP O
DMII NNP I-NP O
, , I-NP O
chronic JJ I-NP O
venous JJ I-NP O
stasis NN I-NP O
, , O O
and CC O O
morbid NN B-NP O
obesity NN I-NP O
presenting VBG B-VP O
with IN B-PP O
shortness NN B-NP O
of IN B-PP O
breath NN B-NP O
likely JJ B-NP O
secondary JJ I-NP O
to TO B-PP O
CHF NNP B-NP O
exacerbation NN I-NP O
from IN B-PP O
right JJ B-NP O
sided JJ I-NP O
failure NN I-NP B-PATIENT
. . O O
Appears NNPS O O
to TO B-VP O
have VB I-VP B-AGE
class NN B-NP O
IV NNP I-NP O
disease NN I-NP O
with IN B-PP O
symptoms NNS B-NP O
at IN B-PP O
rest NN B-NP O
. . O O
BNP NNP B-NP O
is VBZ B-VP O
elevated VBN I-VP O
from IN B-PP O
baseline NN B-NP O
( -LRB- I-NP O
584 CD I-NP O
) -RRB- I-NP O
at IN B-PP O
1625 CD B-NP O
confirming VBG B-VP O
acute JJ B-NP O
exacerbation NN I-NP O
. . O O
Exacerbation NN B-NP O
may MD B-VP O
be VB I-VP O
from IN B-PP O
increased VBN B-NP O
Na NNP I-NP O
intake NN I-NP O
, , O O
medicine NN B-NP O
non-compliance NN I-NP O
and CC O O
increased VBD B-NP O
po NN I-NP O
fluid NN I-NP O
intake NN I-NP O
, , O O
could MD B-VP O
also RB I-VP O
be VB I-VP O
from IN B-PP O
anemia NN B-NP O
. . O O
# # B-NP O
# # I-NP O
: : O O
CHF NNP B-NP O
exacerbation NN I-NP O
&#8211 CD B-NP O
; : O O
patient NN B-NP O
responded VBD B-VP O
well RB B-ADVP O
to TO B-PP O
40mg CD B-NP O
IV NNP I-NP O
lasix NN I-NP O
with IN B-PP O
UOP NNP B-NP O
of IN B-PP O
1 CD B-NP O
L NNP I-NP O
Lasix NNP B-NP O
40mg CD I-NP O
IV NNP I-NP O
BID NNP I-NP O
titrate NN I-NP O
to TO B-PP O
TBB NNP B-NP O
goal NN I-NP O
of IN B-PP O
at IN B-NP O
least JJS I-NP O
-1 NN I-NP O
L NNP I-NP O
( -LRB- I-NP O
will MD B-VP O
likely RB I-VP O
require VB I-VP O
more JJR B-NP O
as IN B-PP O
patient NN B-NP O
required VBN B-VP O
80 CD B-NP O
mg JJ I-NP O
IV NNP I-NP O
TID NNP I-NP O
last JJ B-NP O
admission NN I-NP O
for IN B-PP O
CHF NNP B-NP O
) -RRB- O O
Monitor NNP B-NP O
strict JJ I-NP O
I/O&#8217 NN I-NP O
;s NNS I-NP O
Daily JJ B-NP O
weight NN I-NP O
( -LRB- I-NP O
dry JJ I-NP O
weight NN I-NP O
) -RRB- O O
Na NNP B-NP O
restrict VBP B-VP O
to TO I-VP O
2gm VB I-VP O
, , O O
fluid NN B-NP O
restrict VB B-VP O
to TO I-VP O
2L/day VB I-VP O
Continue NNP B-NP O
lisinopril NN I-NP O
and CC I-NP O
verapamil NN I-NP O
for IN B-PP O
rate NN B-NP O
control NN I-NP O
O2 JJ B-NP O
therapy NN I-NP O
, , O O
titrate NN B-NP O
as IN B-PP O
indicated VBN O O
If IN B-SBAR O
fails VBZ B-NP O
to TO B-VP O
improve VB I-VP O
with IN B-PP O
aggressive JJ B-NP O
diuresis NN I-NP O
, , O O
consider VB B-VP O
PE NN B-NP O
CT NN I-NP O
given VBN I-NP O
history NN I-NP O
of IN B-PP O
immobility NN B-NP O
# # B-NP O
# # I-NP O
: : O O
Anemia NNP B-NP O
&#8211 CD I-NP O
; : O O
iron NN B-NP O
studies NNS I-NP O
last JJ O O
done VBN B-VP O
in IN B-PP O
2116 CD B-NP O
. . O O
Check VB B-VP O
Fe NNP B-NP O
, , I-NP O
TIBC NNP I-NP O
, , I-NP O
ferritin NN I-NP O
, , I-NP O
retic JJ I-NP O
count NN I-NP O
# # B-NP O
# # I-NP O
: : O O
Diabetes NNS B-NP O
Hold VB B-NP O
metformin NN I-NP O
AC NNP B-NP O
and CC I-NP O
HS NNP I-NP O
finger NN I-NP O
sticks NNS I-NP O
Regular JJ B-NP O
insulin NN I-NP O
sliding VBG B-VP O
scale NN B-NP O
# # B-NP O
# # I-NP O
: : O O
Venous JJ B-NP O
stasis NN I-NP O
ulcer NN I-NP O
Continue NNP B-NP O
BID NNP I-NP O
ace NN I-NP O
wraps VBZ B-VP O
with IN B-PP O
calcium NN B-NP O
algenate NN I-NP O
and CC O O
ABDs NNS B-NP O
per IN B-PP O
vascular JJ B-NP O
surgery NN I-NP O
Patient NNP B-NP O
has VBZ B-VP O
appt VBN I-VP O
Thursday NNP B-NP O
. . O O
w/Dr. '' O O
Roe NNP B-NP O
&#8211 CD I-NP O
; : O O
will MD B-VP O
notify VB I-VP O
of IN B-PP O
admission NN B-NP O
# # B-NP O
# # I-NP O
: : O O
OSA NNS B-NP O
CPAP NNP B-NP O
will MD B-VP O
inpatient VB I-VP O
; : O O
will MD B-VP O
attempt VB I-VP O
to TO I-VP O
assist VB I-VP O
patient NN B-NP O
obtaining VBG B-VP O
working VBG B-NP O
machine NN I-NP O
for IN B-PP O
at IN B-NP O
home NN I-NP O
FEN NNS B-NP O
: : O O
Low NNP B-NP O
fat NN I-NP O
, , O O
low JJ B-NP O
cholesterol NN I-NP O
, , O O
no DT B-NP O
concentrated JJ I-NP O
sweets NNS I-NP O
, , O O
2gm JJ B-NP O
sodium NN I-NP O
, , O O
2L JJ B-NP O
fluid NN I-NP O
diet NN I-NP O
PROPHYLAXIS NNS B-NP O
GI NNP B-NP O
: : O O
None NN B-NP O
DVT NNP B-NP O
: : O O
Heparin NNP B-NP O
5000 CD B-NP O
units NNS I-NP O
TID RB B-ADVP O
( -LRB- B-VP O
extreme JJ B-NP O
obesity NN I-NP O
) -RRB- O O
BOWEL NNP B-NP O
: : O O
Colace NNP B-NP O
, , O O
Senna NNP B-NP O
prn NN I-NP O
CODE NNP B-NP O
: : O O
Full NNP B-NP O
code NN I-NP O
Sandra NNP B-NP O
Woody NNP I-NP O
, , O O
MD . O O
PGY-1 NN B-NP O
, , O O
Pager NNP B-NP O
# # I-NP O
23324 CD O O
